This analysis will evaluate the investigators' institution's specific experience using Ru-106 isotopes, cryotherapy, or transpupillary thermotherapy (TTT) to treat persistent or recurrent RB in patients who previously underwent systemic IVC or IAC. The investigators aim to detail the demographics, clinical indications, success rates-specifically local control and globe salvage-, predictive factors for success, and complications of each modality of treatment within a tertiary eye care setting in Egypt.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of Globe salvage for treatment with Brachytherapy
Timeframe: Baseline
Percentage of Globe salvage for treatment with cryotherapy
Timeframe: Baseline
Percentage of Globe salvage for treatment with transpupillary thermotherapy
Timeframe: Baseline